Epidiolex (cannabidiol oral solution) — Highmark

Initial criteria

• age ≥ 1 year
• diagnosis of tuberous sclerosis complex (ICD-10: Q85.1)

Reauthorization criteria

• prescriber attests that the member has experienced a reduction in seizure frequency from baseline

Approval duration

12 months